Mutations in BRCA1 predispose carriers predominantly to cancers of the breast and ovaries (mostly BLBC and HGSOC), though the mechanism driving tumorigenesis in these patients is still unclear. The gene discussed is BRCA1; the disease is breast carcinoma.